Cargando…
Running GAGs: myxoid matrix in tumor pathology revisited: What’s in it for the pathologist?
Ever since Virchow introduced the entity myxoma, abundant myxoid extracellular matrix (ECM) has been recognized in various reactive and neoplastic lesions. Nowadays, the term “myxoid” is commonly used in daily pathological practice. But what do today’s pathologists mean by it, and what does the myxo...
Autores principales: | Willems, Stefan M., Wiweger, Malgorzata, van Roggen, J. Frans Graadt, Hogendoorn, Pancras C. W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828560/ https://www.ncbi.nlm.nih.gov/pubmed/19705152 http://dx.doi.org/10.1007/s00428-009-0822-y |
Ejemplares similares
-
Soft Tissue Tumours of the Retroperitoneum
por: Van Roggen, J. Frans Graadt, et al.
Publicado: (2000) -
Molecular pathology of sarcomas: concepts and clinical implications
por: Bovée, Judith V. M. G., et al.
Publicado: (2009) -
Kinome profiling of myxoid liposarcoma reveals NF-kappaB-pathway kinase activity and Casein Kinase II inhibition as a potential treatment option
por: Willems, Stefan M, et al.
Publicado: (2010) -
HSPG-Deficient Zebrafish Uncovers Dental Aspect of Multiple Osteochondromas
por: Wiweger, Malgorzata I., et al.
Publicado: (2012) -
Possible effects of EXT2 on mesenchymal differentiation - lessons from the zebrafish
por: Wiweger, Malgorzata I, et al.
Publicado: (2014)